The D.R.I.V.E. Initiative for Clinical Trial Excellence

Latest Research for Mantle Cell Lymphoma: Understanding Glofitamab with Dr. Craig Portell

Join us as we unpack the latest research on glofitamab for mantle cell lymphoma (MCL). We’ll break down the study, compare glofitamab to current treatment options, and explain what this could mean for patients facing relapsed or refractory MCL. HealthTree Resources: * News Articles [https://healthtree.org/lymphoma/community/categories/all] * Webinars [https://healthtree.org/lymphoma/community/events?format=webinars&status=past] * HealthTree University [https://healthtree.org/dlbcl/university/modules/yPqDxtbGmHBZa3Dq2jkf] * Connect [https://healthtree.org/lymphoma/connect/group/8wYH4KOs3PIfcuQxLdKU] * Clinical Trial Finder [https://healthtree.org/lymphoma/curehub/]

Early-Stage Research: Exploring the Science Behind a Keto Diet & CAR T Therapy in Lymphoma

This episode explores new preclinical research suggesting that a ketogenic diet may enhance CAR T cell therapy for lymphoma. Join our expert panel as they break down the science, the potential implications, and what’s coming next for a first-in-human clinical trial.   HealthTree Resources: * Connect - Nutrition & Wellness Group [https://healthtree.org/lymphoma/connect/group/BBN6Bmk7wSeU0zaxuHCJ] * Articles - Navigating Your Health [https://healthtree.org/lymphoma/community/categories/navigating-your-health] * Event - Dietary Guidelines for Cancer Prevention After Treatment [https://healthtree.org/lymphoma/community/events/cancer-prevention-dietary-guidelines]   Let me know your thoughts on today's episode! Please share them in a comment or reach out anytime at hannah@healthtree.org [hannah@healthtree.org].

The D.R.I.V.E. Initiative for Clinical Trial Excellence

D.R.I.V.E. is a strategic framework for promoting representative enrollment in clinical trials. D.R.I.V.E. addresses safety and efficacy concerns that arise when studies are conducted in populations that do not reflect the different patient groups that treatments are intended to serve. Join Maya Birhiray, medical science liaison, to learn more about this initiative and its importance in clinical trials. HealthTree Resources: * HealthTree CureHub and Clinical Trial Finder [https://healthtree.org/curehub] * Lymphoma Clinical Trial Articles [https://healthtree.org/follicular-lymphoma/community/categories/clinical-trials] * HealthTree Connect Groups Indy Hematology Education Resources: * The DRIVE Initiative website can be accessed here [https://www.indyhematology.org/review-6wrkb-1]. * The DRIVE Score Calculator can be accessed here [https://drive-score-calculator.vercel.app/]. Let me know your thoughts on today's episode! Please share them in a comment or reach out anytime at hannah@healthtree.org [hannah@healthtree.org].

TRANSCEND FL Trial Updates with Dr. Manali Kamdar

TRANSCEND FL is a global trial assessing the efficacy and safety of the CAR T cell therapy lisocabtagene maraleucel in patients with relapsed or refractory follicular lymphoma. Join Dr. Kamdar, the lead investigator for this trial at University of Colorado Cancer Center, for this podcast to learn more. Feel free to email me with thoughts or questions on this podcast at hannah@healthtree.org [hannah@healthtree.org].   For additional CAR T resources, see below. HealthTree University: * What is CAR-T therapy and how is this drug class used to treat follicular lymphoma?  [https://healthtree.org/follicular-lymphoma/university/courses/MULnyiUAIFFSjjGpJ0zZ] * What is some of the most promising research being done for follicular lymphoma? [https://healthtree.org/follicular-lymphoma/university/courses/nezuou6O4WHJXiZVOQFJ] * What are my options for treating follicular lymphoma? [https://healthtree.org/follicular-lymphoma/university/courses/a8ZgfUsPK12r8XEoDVpn]                 News Articles: * Liso-cel CAR T-Cell Therapy [https://healthtree.org/follicular-lymphoma/community/articles/liso-cel-car-t-follicular-lymphoma-fda] * CAR T-cell Therapy for Follicular Lymphoma [https://healthtree.org/follicular-lymphoma/community/articles/new-car-t-therapy-for-fl]  101 Pages: * What are the Treatments for Follicular Lymphoma? [https://healthtree.org/follicular-lymphoma/community/what-are-treatments-for-follicular-lymphoma]

Follicular Lymphoma Progress in 2024

Listen to this podcast with Dr. Carla Casulo and Judith Trotman to hear about some of the most exciting advancements for follicular lymphoma from the 2024 ASH Conference. ASH News Articles: What is ASH? https://healthtree.org/follicular-lymphoma/community/articles/what-is-the-ash-conference-dlbcl [https://healthtree.org/follicular-lymphoma/community/articles/what-is-the-ash-conference-dlbcl] FL Specialist Insights https://healthtree.org/follicular-lymphoma/community/articles/ash-24-fl-specialists-insights-new-treatments [https://healthtree.org/follicular-lymphoma/community/articles/ash-24-fl-specialists-insights-new-treatments] Best of ASH 2024: https://healthtree.org/follicular-lymphoma/community/articles/ash-24-the-best-of-it-all [https://healthtree.org/follicular-lymphoma/community/articles/ash-24-the-best-of-it-all] ASH Videos:  https://healthtree.org/blood-cancer/university/courses/klLCY3gkYKWHQDry3bkZ [https://healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b]   Let me know your thoughts on today's episode! Feel free to email me with questions, comments, or insights at hannah@healthtree.org [hannah@healthtree.org].